期刊文献+

参附注射液治疗心肌梗死合并心力衰竭患者的临床效果研究 被引量:3

Clinical Efficacy of Shenfu Injection in the Treatment of Patients with Myocardial Infarction Complicated with Heart Failure
暂未订购
导出
摘要 目的:分析参附注射液治疗心肌梗死合并心力衰竭患者的临床效果。方法:选取2017年2月-2018年12月笔者所在医院心内科接受治疗的心肌梗死合并心力衰竭患者57例,根据治疗方法不同将其分为对照组(n=26)和观察组(n=31)。对照组实施常规治疗,观察组在此基础上应用参附注射液治疗。比较两组临床疗效。结果:对照组临床总有效率为65.38%,观察组临床总有效率为90.32%,组间比较差异有统计学意义(P<0.05)。治疗后,观察组心排血量、射血分数均高于对照组,血浆脑钠肽水平低于对照组,差异均有统计学意义(P<0.05)。观察组ESV、LVED水平均低于对照组,E/A高于对照组,差异均有统计学意义(P<0.05)。结论:参附注射液治疗心肌梗死合并心力衰竭患者的临床效果显著,可促使患者心功能的恢复,具有一定的临床疗效。 Objective:To analysis the clinical effects of Shenfu Injection in the treatment of patients with myocardial infarction complicated with heart failure.Method:A total of 57 patients with myocardial infarction complicated with heart failure who were treated in the Department of Cardiology of our hospital from February 2017 to December 2018 were selected.According to different treatment methods,they were divided into the control group(n=26)and the observation group(n=31).The control group received routine treatment.The observation group received Shenfu Injection on this basis.The clinical efficacy of the two groups was compared.Result:The total clinical effective rate in the control group was 65.38%,and the total clinical effective rate in the observation group was 90.32%.There was a statistically significant difference between the groups(P<0.05).After treatment,the cardiac output and ejection fraction of the observation group were higher than those of the control group,and the plasma brain natriuretic peptide level were lower than that of the control group,and the differences were statistically significant(P<0.05).The level of ESV and LVED of the observation group were lower than those of the control group,and E/A was higher than that of the control group,and the differences were statistically significant(P<0.05).Conclusion:Shenfu Injection has obvious clinical effect on patients with myocardial infarction complicated with heart failure,which can promote the recovery of patients’cardiac function and has certain clinical effect.
作者 张毅 况成宏 ZHANG Yi;KUANG Chenghong(Xiangyang Integrated Traditional Chinese and Western Medicine Hospital,Xiangyang 441000,China)
出处 《中外医学研究》 2019年第36期42-44,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 心肌梗死 心力衰竭 参附注射液 疗效 心功能 Myocardial infarction Heart failure Shenfu Injection Efficacy Cardiac function
  • 相关文献

参考文献12

二级参考文献103

  • 1赵桂先.参附注射液在心血管疾病中的临床应用[J].求医问药(下半月),2013(4):283-283. 被引量:3
  • 2刘新,刘欣,杨引,张良清.参附注射液对缺血再灌注心肌炎症反应的影响[J].湖北民族学院学报(医学版),2006,23(2):10-11. 被引量:12
  • 3柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2244
  • 4中华医学会心血管病分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗指南.中华心血管病杂志,2007,:1091-1091.
  • 5无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3756
  • 6Killip T,Kimball JT.Treatm ent of myocardial infarction in a coronary care unit.A two year experience with 250 patients[J].Am J Cardiol,1967,20(4):457.
  • 7Randhawa MS,Dhillon AS,Desai MY.Incremental use of biomarkers and electrocardiogram in differentiating takot-subo cardiomyopathy from acute myocardial infarction:Apotential way to go[J].J Card Fail,2014,20(4):292-293.
  • 8Salzano A,Sirico D,Arcopinto M,et al.Anti remodeling therapy:new strategies and future perspective in post-ischemic heart failure.PartⅡ[J].Monaldi Arch Chest Dis,2014,82(4):195-201.
  • 9Grover P,Fitzgibbons TP.Spontaneous coronary artery dissection in a patient with autosomal dominant polycystic kidney disease:a case report[J].J Med Case Rep,2016,10(1):62.
  • 10Sirico D,Salzano A,Celentani D,et al.Anti remodeling therapy:new strategies and future perspective in post-ischemic heart failure:PartⅠ[J].Monaldi Arch Chest Dis,2014,82(4):187-194.

共引文献5379

同被引文献84

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部